Administration of AS03B-adjuvanted A(H1N1)pdm09 Vaccine in Children Aged  | Zendy

Katja Höschler | Zendy; Nick Andrews | Zendy; Saul N. Faust | Zendy; Adam Finn | Zendy; Andrew J. Pollard | Zendy; Matthew D. Snape | Zendy; W. Thomson Walker | Zendy; Maria Zambon | Zendy; Elizabeth Miller | Zendy

Open Access

Administration of AS03B-adjuvanted A(H1N1)pdm09 Vaccine in Children Aged <3 Years Enhances Antibody Response to H3 and B Viruses Following a Single Dose of Trivalent Vaccine One Year Later

Author(s) -

Katja Höschler,

Nick Andrews,

Saul N. Faust,

Adam Finn,

Andrew J. Pollard,

Matthew D. Snape,

W. Thomson Walker,

Maria Zambon,

Elizabeth Miller

Publication year - 2013

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cit692

Subject(s) - medicine , virology , antibody , influenza vaccine , antibody response , serology , immunology , trivalent influenza vaccine , virus , hemagglutination assay , vaccination , titer

We report on a follow-up clinical and serological investigation of 274 children who received seasonal influenza vaccine (trivalent inactivated vaccine [TIV]) 1 year after receipt of either AS03(B)-adjuvanted subunit or whole virus monovalent A(H1N1)pdm09 vaccine and describe the antibody responses to the H3N2 A/Perth/16/2009 and B/Brisbane/60/2008 components of TIV.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research